T1	Participants 402 475	Thirteen female patients (6 in the United States and 7 in Poland) with IC
T2	Participants 653 670	(Polish patients)
T3	Participants 680 694	(U.S. patients
T4	Participants 804 812	Patients
T5	Participants 992 1011	The Polish patients
T6	Participants 1100 1151	9 (69%) of 13 patients noted subjective improvement
T7	Participants 1646 1663	patients with IC,
